Inhibition of uridine incorporation in proerythroblasts patients with alpha-methyldopa induced haemolytic anaemia.
D000743:Anemia, Hemolytic / Q000139:chemically induced* / Q000378:metabolism; D000818:Animals; D001345:Autoradiography; D003298:Coombs Test; D004912:Erythrocytes / Q000378:metabolism*; D005260:Female; D006412:Hematopoietic Stem Cells / Q000378:metabolism*; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D006834:Hydrazines; D006973:Hypertension; D007274:Injections, Intraperitoneal; D008297:Male; D008750:Methyldopa / Q000009:adverse effects*; D051379:Mice; D008875:Middle Aged; D009996:Osmotic Fragility; D011239:Prednisolone / Q000627:therapeutic use; D012156:Reticulocytes; D013936:Thymidine / Q000378:metabolism; D014316:Tritium; D014529:Uridine / Q000378:metabolism*
D006454:Hemoglobins; D006834:Hydrazines; D014316:Tritium; D008750:Methyldopa; D011239:Prednisolone; D013936:Thymidine; D014529:Uridine